Principal Financial Group
KROS icon

Principal Financial Group’s Keros Therapeutics KROS Stock Holding History

Principal Financial Group’s Portfolio KROS Stock Details KROS Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$658K Buy
2024
Q3 		– Sell
2024
Q2 		$241K Sell
2024
Q1 		$468K Buy
2023
Q4 		$258K Sell
2023
Q3 		$208K Sell
2023
Q2 		$266K Buy
2023
Q1 		$251K Sell
2022
Q4 		$301K Buy
2021
Q1 		– Sell
2020
Q4 		$221K Buy